Physician profile
Eric Penedo
NPI 1467687590
$987.13
in general payments reported to CMS, 2019-2025
19 companies · $118 in 2025
The $118 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $41.16 · 2021: $16.79 · 2022: $163 · 2023: $191 · 2024: $232 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $195.21 | 2019-2024 | Farxiga, Lokelma |
| Abbvie INC. | $91.77 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $91.24 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $77.91 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $65.08 | 2023-2024 | Inpefa |
| Edwards Lifesciences Corporation | $57.18 | 2022 | |
| Novartis Pharmaceuticals Corporation | $56.09 | 2023-2024 | |
| Portola Pharmaceuticals, LLC | $53.78 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.79 | 2019-2025 | Xifaxan |
| Alexion Pharmaceuticals, INC. | $43.43 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $34.53 | 2024 | |
| Allergan, INC. | $31.49 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.06 | 2025 | Jardiance |
| Csl Behring | $23.59 | 2025 | Kcentra |
| Inspire Medical Systems, INC. | $18.93 | 2025 | Inspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $17.89 | 2023 | Terlivaz |
| Pfizer INC. | $17.80 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.79 | 2021 | |
| Merck Sharp & Dohme LLC | $13.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Penedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.